|
Faiz Mohammed
|
Interim CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Sep 2026 |
63,532 |
63,532
|
-
|
|
-
|
Restricted Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2026 |
7,147 |
19,030
|
-
|
|
0
|
Common Stock |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2026 |
7,147 |
7,147
|
-
|
|
-
|
Restricted Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.82 per share. |
01 Jun 2026 |
2,241 |
16,789
|
-
|
5.8 |
13,043
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.82 per share. |
01 Jun 2026 |
7,893 |
32,046
|
-
|
5.8 |
45,937
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2026 |
14,889 |
39,939
|
-
|
|
0
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.82 per share. |
01 Jun 2026 |
4,210 |
25,050
|
-
|
5.8 |
24,502
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2026 |
7,941 |
29,260
|
-
|
|
0
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2026 |
14,889 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2026 |
7,941 |
7,941
|
-
|
|
-
|
Restricted Stock Units |
|
Cynthia Lynne Collins
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Cynthia Lynne Collins
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
51,846
|
-
|
|
0
|
Common Stock |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
213,316
|
-
|
|
0
|
Common Stock |
|
Matthew M. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 May 2026 |
33,222 |
33,222
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director, Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 May 2026 |
33,222 |
33,222
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
50,708
|
-
|
|
0
|
Common Stock |
|
James E. Cashman
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
484,197
|
-
|
|
0
|
Common Stock |
|
James E. Cashman
|
Director, Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 May 2026 |
33,222 |
33,222
|
-
|
|
-
|
Restricted Stock Units |
|
Rosemary A. Crane
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
45,672
|
-
|
|
0
|
Common Stock |
|
Rosemary A. Crane
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
51,846
|
-
|
|
0
|
Common Stock |
|
Nancy Killefer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 May 2026 |
33,222 |
33,222
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
John V. W. Reynders
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 May 2026 |
33,222 |
33,222
|
-
|
|
-
|
Restricted Stock Units |
|
John V. W. Reynders
|
Director, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
26,466
|
-
|
|
0
|
Common Stock |
|
John V. W. Reynders
|
Director, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
15,757 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Arjun Bedi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 May 2026 |
33,222 |
33,222
|
-
|
|
-
|
Restricted Stock Units |
|
Arjun Bedi
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
5,547 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Arjun Bedi
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2026 |
5,547 |
5,547
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 May 2026 |
68,348 |
0
|
-
|
|
-
|
Performance Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
111,111 |
111,111
|
-
|
|
-
|
Performance Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
74,074 |
74,074
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
68,348 |
68,348
|
-
|
|
-
|
Performance Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 May 2026 |
102,522 |
0
|
-
|
|
-
|
Performance Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
194,444 |
194,444
|
-
|
|
-
|
Performance Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
129,629 |
129,629
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
102,522 |
102,522
|
-
|
|
-
|
Performance Stock Units |
|
Jon Resnick
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
728,405 |
728,405
|
-
|
|
-
|
Restricted Stock Units |
|
Jon Resnick
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 May 2026 |
59,766 |
119,533
|
-
|
|
-
|
Restricted Stock Units |
|
Jon Resnick
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 May 2026 |
59,766 |
59,766
|
-
|
|
0
|
Common Stock |
|
Jon Resnick
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.31 per share. |
11 May 2026 |
24,377 |
35,389
|
-
|
6.3 |
153,819
|
Common Stock |
|
Jon Resnick
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
268,949 |
268,949
|
-
|
|
-
|
Performance Stock Units |
|
Jon Resnick
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
740,740 |
740,740
|
-
|
|
-
|
Performance Stock Units |
|
Jon Resnick
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
179,299 |
179,299
|
-
|
|
-
|
Restricted Stock Units |
|
Jon Resnick
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
493,827 |
493,827
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
86,419 |
86,419
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 May 2026 |
68,348 |
0
|
-
|
|
-
|
Performance Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
129,629 |
129,629
|
-
|
|
-
|
Performance Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
246,913 |
246,913
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
68,348 |
68,348
|
-
|
|
-
|
Performance Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
92,592 |
92,592
|
-
|
|
-
|
Performance Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 May 2026 |
43,938 |
0
|
-
|
|
-
|
Performance Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
43,938 |
43,938
|
-
|
|
-
|
Performance Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
61,728 |
61,728
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
74,074 |
74,074
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 May 2026 |
48,820 |
0
|
-
|
|
-
|
Performance Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
48,820 |
48,820
|
-
|
|
-
|
Performance Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 May 2026 |
111,111 |
111,111
|
-
|
|
-
|
Performance Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2026 |
14,510 |
88,489
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
15,188 |
30,378
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,127 |
10,127
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
7,852 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
3,699 |
110,045
|
-
|
5.7 |
21,084
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
15,188 |
113,744
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
2,466 |
98,556
|
-
|
5.7 |
14,056
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,127 |
101,022
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
1,912 |
90,895
|
-
|
5.7 |
10,898
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
7,852 |
92,807
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
3,534 |
84,955
|
-
|
5.7 |
20,144
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
7,775 |
62,099
|
-
|
5.7 |
44,318
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2026 |
23,346 |
69,874
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
12,633 |
74,732
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
01 Apr 2026 |
4,327 |
70,405
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
15,190 |
85,595
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
5,203 |
80,392
|
-
|
5.7 |
29,657
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
22,782 |
103,174
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
7,803 |
95,371
|
-
|
5.7 |
44,477
|
Common Stock |
|
John E. Gallagher
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
12,633 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
15,190 |
15,191
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
22,782 |
45,566
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,127 |
329,153
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
7,852 |
322,717
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
6,821 |
314,865
|
-
|
5.7 |
38,880
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2026 |
14,510 |
321,686
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
15,188 |
30,378
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,127 |
10,127
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
7,852 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
7,139 |
332,442
|
-
|
5.7 |
40,692
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
15,188 |
339,581
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
4,760 |
324,393
|
-
|
5.7 |
27,132
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
3,691 |
319,026
|
-
|
5.7 |
21,039
|
Common Stock |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
9,764 |
14,945
|
-
|
|
0
|
Common Stock |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
3,062 |
11,883
|
-
|
5.7 |
17,453
|
Common Stock |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
9,764 |
19,528
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,849 |
27,070
|
-
|
|
0
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
5,751 |
21,319
|
-
|
5.7 |
32,781
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,849 |
21,698
|
-
|
|
-
|
Restricted Stock Units |
|
Adrian McKemey
|
President, Drug Dev. Solutions |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,849 |
10,849
|
-
|
|
0
|
Common Stock |
|
Adrian McKemey
|
President, Drug Dev. Solutions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. |
01 Apr 2026 |
2,642 |
8,207
|
-
|
5.7 |
15,059
|
Common Stock |
|
Adrian McKemey
|
President, Drug Dev. Solutions |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2026 |
10,849 |
21,698
|
-
|
|
-
|
Restricted Stock Units |
|
Arjun Bedi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Feb 2026 |
5,547 |
5,547
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
11 Nov 2025 |
24,096 |
2,360,769
|
-
|
8.3 |
200,000
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Sale of securities on an exchange or to another person at price $ 10.92 per share. |
09 Sep 2025 |
51,224 |
73,979
|
-
|
10.9 |
559,366
|
Common Stock |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 May 2025 |
7,146 |
7,146
|
-
|
|
0
|
Common Stock |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 May 2025 |
7,146 |
14,294
|
-
|
|
-
|
Restricted Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. |
30 May 2025 |
1,965 |
5,181
|
-
|
11.4 |
22,401
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. |
30 May 2025 |
4,309 |
16,221
|
-
|
11.4 |
49,123
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 May 2025 |
14,888 |
20,530
|
-
|
|
0
|
Comon Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 May 2025 |
7,940 |
7,940
|
-
|
|
0
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. |
30 May 2025 |
2,298 |
5,642
|
-
|
11.4 |
26,197
|
Common Stock |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 May 2025 |
14,888 |
14,889
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 May 2025 |
7,940 |
15,882
|
-
|
|
-
|
Restricted Stock Units |
|
Cynthia Lynne Collins
|
Director |
|
21 May 2025 |
15,757 |
15,757
|
-
|
|
-
|
Restricted Stock Units |
|
Cynthia Lynne Collins
|
Director |
|
21 May 2025 |
11,928 |
36,089
|
-
|
|
0
|
Common Stock |
|
Cynthia Lynne Collins
|
Director |
|
21 May 2025 |
11,928 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
197,559
|
-
|
|
0
|
Common Stock |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2025 |
15,757 |
15,757
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director, Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2025 |
15,757 |
15,757
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
34,951
|
-
|
|
0
|
Common Stock |
|
Eran Broshy
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director, Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2025 |
15,757 |
15,757
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
468,440
|
-
|
|
0
|
Common Stock |
|
Rosemary A. Crane
|
Director |
|
21 May 2025 |
11,928 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Rosemary A. Crane
|
Director |
|
21 May 2025 |
15,757 |
15,757
|
-
|
|
-
|
Restricted Stock Units |
|
Rosemary A. Crane
|
Director |
|
21 May 2025 |
11,928 |
29,915
|
-
|
|
0
|
Common Stock |
|
Nancy Killefer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2025 |
15,757 |
15,757
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
36,089
|
-
|
|
0
|
Common Stock |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
11,928 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
John V. W. Reynders
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
10,709 |
10,709
|
-
|
|
0
|
Common Stock |
|
John V. W. Reynders
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2025 |
15,757 |
15,757
|
-
|
|
-
|
Restricted Stock Units |
|
John V. W. Reynders
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2025 |
10,709 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
20 May 2025 |
280,716 |
280,716
|
-
|
|
-
|
Performance Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
20 May 2025 |
187,144 |
187,144
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
45,566 |
45,566
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
68,348 |
68,348
|
-
|
|
-
|
Performance Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
102,522 |
102,522
|
-
|
|
-
|
Performance Stock Units |
|
John E. Gallagher
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
68,348 |
68,348
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
68,348 |
68,348
|
-
|
|
-
|
Performance Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
45,566 |
45,566
|
-
|
|
-
|
Restricted Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
43,938 |
43,938
|
-
|
|
-
|
Performance Stock Units |
|
Rona S. Anhalt
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
29,292 |
29,292
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
32,547 |
32,547
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel D. Corcoran
|
SVP and General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
48,820 |
48,820
|
-
|
|
-
|
Performance Stock Units |
|
Adrian McKemey
|
President, Drug Dev. Solutions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
48,820 |
48,820
|
-
|
|
-
|
Performance Stock Units |
|
Adrian McKemey
|
President, Drug Dev. Solutions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2025 |
32,547 |
32,547
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
29,960 |
2,279,114
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
8,238 |
2,270,876
|
-
|
9.9 |
81,556
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
36,580 |
2,307,456
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
13,807 |
2,293,649
|
-
|
9.9 |
136,689
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
33,220 |
2,326,869
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
14,116 |
2,312,753
|
-
|
9.9 |
139,748
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
41,593 |
2,354,346
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
17,673 |
2,336,673
|
-
|
9.9 |
174,963
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
36,580 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
33,220 |
33,220
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2025 |
41,593 |
83,186
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
10,127 |
20,254
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2025 |
7,082 |
106,786
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
1,725 |
105,061
|
-
|
9.9 |
17,078
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
8,647 |
113,708
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
2,106 |
111,602
|
-
|
9.9 |
20,849
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
7,852 |
119,454
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
1,912 |
117,542
|
-
|
9.9 |
18,929
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
10,127 |
127,669
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
2,466 |
125,203
|
-
|
9.9 |
24,413
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
8,647 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
7,852 |
7,852
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
12,633 |
40,868
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
4,327 |
36,541
|
-
|
9.9 |
42,837
|
Common Stock |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
15,190 |
51,731
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
5,203 |
46,528
|
-
|
9.9 |
51,510
|
Common Stock |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
14,663 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
12,633 |
12,633
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
15,190 |
30,381
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
14,663 |
32,881
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
4,646 |
28,235
|
-
|
9.9 |
45,995
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2025 |
7,082 |
296,396
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
8,647 |
301,713
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
3,330 |
293,066
|
-
|
9.9 |
32,967
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
4,065 |
297,648
|
-
|
9.9 |
40,244
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
7,852 |
305,500
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
3,691 |
301,809
|
-
|
9.9 |
36,541
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
10,127 |
311,936
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. |
01 Apr 2025 |
4,760 |
307,176
|
-
|
9.9 |
47,124
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
8,647 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
7,852 |
7,852
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, PREDICTIVE TECH |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2025 |
10,127 |
20,254
|
-
|
|
-
|
Restricted Stock Units |
|
John V. W. Reynders
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Oct 2024 |
10,709 |
10,709
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
07 Oct 2024 |
5,409 |
50,091
|
-
|
11.0 |
59,661
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
04 Oct 2024 |
7,151 |
57,242
|
-
|
|
0
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
04 Oct 2024 |
1,742 |
55,500
|
-
|
11.0 |
19,145
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
04 Oct 2024 |
7,151 |
14,303
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Sale of securities on an exchange or to another person at price $ 11.29 per share. |
09 Sep 2024 |
51,224 |
99,704
|
-
|
11.3 |
578,319
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SCIENTIFIC SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.85 per share. |
01 Jul 2024 |
862 |
289,314
|
-
|
13.9 |
11,939
|
Common Stock |
|
Rona Anhalt
|
Chief Human Resources Officer |
|
01 Jun 2024 |
21,440 |
21,440
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel Corcoran
|
SVP and General Counsel |
|
01 Jun 2024 |
23,822 |
23,822
|
-
|
|
-
|
Restricted Stock Units |
|
Daniel Corcoran
|
SVP and General Counsel |
|
01 Jun 2024 |
29,777 |
29,777
|
-
|
|
-
|
Restricted Stock Units |
|
Cynthia Collins
|
Director |
|
21 May 2024 |
8,663 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Cynthia Collins
|
Director |
|
21 May 2024 |
8,663 |
24,161
|
-
|
|
0
|
Common Stock |
|
Cynthia Collins
|
Director |
|
21 May 2024 |
11,928 |
11,928
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2024 |
11,928 |
11,928
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
185,631
|
-
|
|
0
|
Common Stock |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
23,023
|
-
|
|
0
|
Common Stock |
|
Eran Broshy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2024 |
11,928 |
11,928
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director, Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2024 |
11,928 |
11,928
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
456,512
|
-
|
|
0
|
Common Stock |
|
James E. Cashman
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Rosemary A. Crane
|
Director |
|
21 May 2024 |
11,928 |
11,928
|
-
|
|
-
|
Restricted Stock Units |
|
Rosemary A. Crane
|
Director |
|
21 May 2024 |
8,663 |
17,987
|
-
|
|
0
|
Common Stock |
|
Rosemary A. Crane
|
Director |
|
21 May 2024 |
8,663 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 May 2024 |
11,928 |
11,928
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2024 |
8,663 |
24,161
|
-
|
|
0
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
02 Apr 2024 |
422 |
50,091
|
-
|
17.8 |
7,499
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
02 Apr 2024 |
4,740 |
50,513
|
-
|
16.8 |
79,490
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
02 Apr 2024 |
328 |
55,253
|
-
|
17.7 |
5,796
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
02 Apr 2024 |
3,024 |
55,581
|
-
|
16.8 |
50,652
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
02 Apr 2024 |
649 |
58,605
|
-
|
17.7 |
11,500
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
02 Apr 2024 |
5,264 |
59,254
|
-
|
16.8 |
88,225
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
36,580 |
36,580
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
14,115 |
2,249,154
|
-
|
17.9 |
252,376
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
33,219 |
2,263,269
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
15,543 |
2,230,050
|
-
|
17.9 |
277,909
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
36,580 |
2,245,593
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
12,971 |
2,209,013
|
-
|
17.9 |
231,921
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2024 |
120,981 |
120,981
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
33,219 |
66,440
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
2,106 |
144,988
|
-
|
17.9 |
37,655
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
7,852 |
152,840
|
-
|
|
0
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
1,912 |
150,928
|
-
|
17.9 |
34,187
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
8,646 |
8,647
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
7,852 |
15,704
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2024 |
30,381 |
30,381
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
1,933 |
138,448
|
-
|
17.9 |
34,562
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
8,646 |
147,094
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
14,663 |
14,663
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
12,632 |
25,266
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2024 |
45,571 |
45,571
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
14,663 |
14,663
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
4,750 |
9,913
|
-
|
17.9 |
84,930
|
Common Stock |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
12,632 |
22,545
|
-
|
|
0
|
Common Stock |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
4,327 |
18,218
|
-
|
17.9 |
77,367
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
8,646 |
290,079
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2024 |
30,381 |
30,381
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
7,852 |
15,704
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
8,646 |
8,647
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
3,691 |
290,176
|
-
|
17.9 |
65,995
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2024 |
7,852 |
293,867
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
2,870 |
281,433
|
-
|
17.9 |
51,316
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
01 Apr 2024 |
4,064 |
286,015
|
-
|
17.9 |
72,664
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
3,000 |
173,524
|
-
|
18 |
54,000
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
1,723 |
167,750
|
-
|
17.9 |
30,807
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
6,651 |
174,401
|
-
|
|
0
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
2,245 |
172,156
|
-
|
17.9 |
40,141
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
6,644 |
178,800
|
-
|
|
0
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
2,276 |
176,524
|
-
|
17.9 |
40,695
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
6,651 |
6,651
|
-
|
|
-
|
Restricted Stock Units |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2024 |
6,644 |
13,288
|
-
|
|
-
|
Restricted Stock Units |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2024 |
4,228 |
8,456
|
-
|
|
-
|
Restricted Stock Units |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2024 |
3,991 |
3,991
|
-
|
|
-
|
Restricted Stock Units |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2024 |
1,326 |
24,358
|
-
|
17.9 |
23,709
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2024 |
4,228 |
25,684
|
-
|
|
0
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2024 |
1,252 |
21,456
|
-
|
17.9 |
22,386
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2024 |
3,991 |
22,708
|
-
|
|
0
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2024 |
15,190 |
15,190
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
8,646 |
62,089
|
-
|
|
0
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
7,852 |
67,208
|
-
|
|
0
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
2,690 |
64,518
|
-
|
17.9 |
48,097
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
8,646 |
8,647
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
7,852 |
15,704
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
30,381 |
30,381
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
1,532 |
53,443
|
-
|
17.9 |
27,392
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
01 Apr 2024 |
2,733 |
59,356
|
-
|
17.9 |
48,866
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2024 |
124,779 |
124,779
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. |
05 Mar 2024 |
4,050 |
140,381
|
-
|
18.9 |
76,464
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Mar 2024 |
15,548 |
144,431
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. |
05 Mar 2024 |
1,689 |
284,303
|
-
|
18.9 |
31,888
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Mar 2024 |
11,960 |
288,025
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. |
05 Mar 2024 |
5,622 |
282,403
|
-
|
18.9 |
106,143
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT; SCIENTIFIC SOFTWARE |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Mar 2024 |
3,589 |
285,992
|
-
|
|
0
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
05 Mar 2024 |
3,660 |
169,473
|
-
|
18.9 |
69,101
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
05 Mar 2024 |
10,765 |
173,133
|
-
|
|
0
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
05 Mar 2024 |
2,373 |
18,717
|
-
|
18.9 |
44,802
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
05 Mar 2024 |
6,600 |
21,090
|
-
|
|
0
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
04 Mar 2024 |
3,000 |
162,368
|
-
|
18.3 |
54,840
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
20 Feb 2024 |
5,000 |
54,975
|
-
|
18 |
90,000
|
Common Stock |
|
Traynor M. Richard
|
SVP AND GENERAL COUNSEL |
|
12 Feb 2024 |
6,000 |
165,368
|
-
|
18 |
108,000
|
Common Stock |
|
M. Traynor Richard
|
SVP AND GENERAL COUNSEL |
|
26 Dec 2023 |
6,000 |
171,368
|
-
|
18 |
108,000
|
Common Stock |
|
Smith F Patrick
|
PRESIDENT, DRUG DEV SOLUTIONS |
|
05 Oct 2023 |
21,454 |
21,454
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, CHIEF COMMERCAL OFF |
Sale of securities on an exchange or to another person at price $ 14.60 per share. |
11 Sep 2023 |
51,224 |
128,883
|
-
|
14.6 |
747,870
|
Common Stock |
|
Eran Broshy
|
Director |
Purchase of securities on an exchange or from another person at price $ 15.80 per share. |
21 Aug 2023 |
4,807 |
14,360
|
-
|
15.8 |
75,951
|
Common Stock |
|
Eran Broshy
|
Director |
Purchase of securities on an exchange or from another person at price $ 16.10 per share. |
21 Aug 2023 |
193 |
9,553
|
-
|
16.1 |
3,107
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Aug 2023 |
1,057 |
14,490
|
-
|
19.5 |
20,580
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.19 per share. |
30 Jun 2023 |
862 |
276,065
|
-
|
18.2 |
15,680
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
05 Jun 2023 |
19,104 |
59,975
|
-
|
21.5 |
411,691
|
Common Stock |
|
Cynthia Collins
|
Director |
|
23 May 2023 |
8,663 |
8,663
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 May 2023 |
8,663 |
8,663
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 May 2023 |
9,360 |
9,360
|
-
|
|
0
|
Common Stock |
|
Eran Broshy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 May 2023 |
8,663 |
8,663
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 May 2023 |
9,360 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 May 2023 |
8,663 |
8,663
|
-
|
|
-
|
Restricted Stock Units |
|
Rosemary A. Crane
|
Director |
|
23 May 2023 |
9,324 |
9,324
|
-
|
|
0
|
Common Stock |
|
Rosemary A. Crane
|
Director |
|
23 May 2023 |
8,663 |
8,663
|
-
|
|
-
|
Restricted Stock Units |
|
Rosemary A. Crane
|
Director |
|
23 May 2023 |
9,324 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 May 2023 |
8,663 |
8,663
|
-
|
|
-
|
Restricted Stock Units |
|
Cynthia Collins
|
Director |
|
17 May 2023 |
9,067 |
15,498
|
-
|
|
0
|
Common Stock |
|
Cynthia Collins
|
Director |
|
17 May 2023 |
9,067 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 May 2023 |
9,067 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 May 2023 |
9,067 |
176,968
|
-
|
|
0
|
Common Stock |
|
James E. Cashman
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 May 2023 |
9,067 |
447,849
|
-
|
|
0
|
Common Stock |
|
James E. Cashman
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 May 2023 |
9,067 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 May 2023 |
9,067 |
15,498
|
-
|
|
0
|
Common Stock |
|
Nancy Killefer
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 May 2023 |
9,067 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
11 May 2023 |
5,000 |
177,368
|
-
|
20.8 |
104,100
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
14 Apr 2023 |
5,000 |
182,368
|
-
|
23.7 |
118,300
|
Common Stock |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2023 |
37,898 |
37,898
|
-
|
|
-
|
Restricted Stock Units |
|
John E. Gallagher
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2023 |
29,326 |
29,326
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
31 Mar 2023 |
99,659 |
99,659
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
31 Mar 2023 |
36,580 |
73,160
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
31 Mar 2023 |
15,543 |
2,179,742
|
-
|
23.8 |
369,923
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
31 Mar 2023 |
36,580 |
2,195,285
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
31 Mar 2023 |
10,091 |
2,158,705
|
-
|
23.8 |
240,166
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. |
31 Mar 2023 |
2,106 |
180,107
|
-
|
23.8 |
50,123
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. |
31 Mar 2023 |
1,933 |
173,567
|
-
|
23.8 |
46,005
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
8,646 |
17,293
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
23,556 |
23,556
|
-
|
|
-
|
Restricted Stock Units |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
8,646 |
182,213
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
8,646 |
280,991
|
-
|
|
0
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. |
31 Mar 2023 |
2,870 |
272,345
|
-
|
23.8 |
68,306
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. |
31 Mar 2023 |
4,064 |
276,927
|
-
|
23.8 |
96,723
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
8,646 |
17,293
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
23,556 |
23,556
|
-
|
|
-
|
Restricted Stock Units |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
31 Mar 2023 |
6,651 |
189,492
|
-
|
|
0
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
31 Mar 2023 |
1,723 |
182,841
|
-
|
23.8 |
41,007
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
31 Mar 2023 |
19,932 |
19,932
|
-
|
|
-
|
Restricted Stock Units |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
31 Mar 2023 |
6,651 |
13,302
|
-
|
|
-
|
Restricted Stock Units |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
31 Mar 2023 |
2,124 |
187,368
|
-
|
23.8 |
50,551
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. |
31 Mar 2023 |
3,721 |
514,149
|
-
|
23.8 |
88,560
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
13,302 |
26,604
|
-
|
|
-
|
Restricted Stock Units |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. |
31 Mar 2023 |
4,556 |
522,895
|
-
|
23.8 |
108,433
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
13,302 |
527,451
|
-
|
|
0
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
31 Mar 2023 |
3,990 |
16,798
|
-
|
|
0
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
31 Mar 2023 |
12,684 |
12,684
|
-
|
|
-
|
Restricted Stock Units |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
31 Mar 2023 |
3,990 |
7,982
|
-
|
|
-
|
Restricted Stock Units |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
31 Mar 2023 |
1,251 |
15,547
|
-
|
23.8 |
29,774
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
31 Mar 2023 |
8,646 |
81,973
|
-
|
|
0
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
31 Mar 2023 |
2,894 |
79,079
|
-
|
23.8 |
68,877
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
31 Mar 2023 |
1,532 |
73,327
|
-
|
23.8 |
36,462
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
31 Mar 2023 |
23,556 |
23,556
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
31 Mar 2023 |
8,646 |
17,293
|
-
|
|
-
|
Restricted Stock Units |
|
Drayton Virkler
|
PRESIDENT, REG & ACCES |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
23,556 |
23,556
|
-
|
|
-
|
Restricted Stock Units |
|
Drayton Virkler
|
PRESIDENT, REG & ACCES |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
3,990 |
7,982
|
-
|
|
-
|
Restricted Stock Units |
|
Drayton Virkler
|
PRESIDENT, REG & ACCES |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. |
31 Mar 2023 |
1,166 |
12,415
|
-
|
23.8 |
27,751
|
Common Stock |
|
Drayton Virkler
|
PRESIDENT, REG & ACCES |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
3,990 |
13,581
|
-
|
|
0
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
06 Mar 2023 |
10,000 |
184,564
|
-
|
21.5 |
214,500
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
05 Mar 2023 |
59,799 |
2,239,541
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
05 Mar 2023 |
17,557 |
2,221,984
|
-
|
18.9 |
331,476
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
02 Feb 2023 |
15,000 |
194,564
|
-
|
20 |
300,000
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Sale of securities on an exchange or to another person at price $ 15.55 per share. |
22 Nov 2022 |
51,223 |
175,500
|
-
|
15.6 |
796,518
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 15.57 per share. |
14 Nov 2022 |
245,793 |
660,322
|
-
|
15.6 |
3,826,997
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 15.27 per share. |
14 Nov 2022 |
4,207 |
906,115
|
-
|
15.3 |
64,241
|
Common Stock |
|
Matthew M. Walsh
|
Director |
Sale of securities on an exchange or to another person at price $ 14.74 per share. |
14 Nov 2022 |
12,059 |
167,901
|
-
|
14.7 |
177,750
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
09 Nov 2022 |
2,387 |
74,859
|
-
|
13.5 |
32,177
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
01 Nov 2022 |
1,244 |
77,246
|
-
|
12.2 |
15,214
|
Common Stock |
|
Drayton Virkler
|
INTERIM PRESIDENT, REG & ACCES |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Oct 2022 |
17,440 |
17,440
|
-
|
|
-
|
Restricted Stock Units |
|
Drayton Virkler
|
INTERIM PRESIDENT, REG & ACCES |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Sep 2022 |
3,021 |
13,595
|
-
|
|
0
|
Common Stock |
|
Drayton Virkler
|
INTERIM PRESIDENT, REG & ACCES |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Sep 2022 |
3,021 |
6,042
|
-
|
|
-
|
Restricted Stock Units |
|
Drayton Virkler
|
INTERIM PRESIDENT, REG & ACCES |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Sep 2022 |
10,574 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Drayton Virkler
|
INTERIM PRESIDENT, REG & ACCES |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. |
30 Sep 2022 |
4,004 |
9,591
|
-
|
13.3 |
53,293
|
Common stock |
|
Drayton Virkler
|
INTERIM PRESIDENT, REG & ACCES |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Sep 2022 |
10,574 |
10,574
|
-
|
|
0
|
Common Stock |
|
Stephen M. McLean
|
Director |
Purchase of securities on an exchange or from another person at price $ 16.32 per share. |
19 Aug 2022 |
20,000 |
42,000
|
-
|
16.3 |
326,400
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Purchase of securities on an exchange or from another person at price $ 16.64 per share. |
17 Aug 2022 |
25,000 |
517,870
|
-
|
16.6 |
416,000
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 17.38 per share. |
16 Aug 2022 |
182,475 |
910,322
|
-
|
17.4 |
3,171,416
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
16 Aug 2022 |
10,000 |
78,490
|
-
|
17.7 |
177,100
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Aug 2022 |
1,755 |
12,808
|
-
|
23.0 |
40,347
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Aug 2022 |
1,057 |
14,563
|
-
|
23.0 |
24,300
|
Common Stock |
|
Rosemary A. Crane
|
Director |
|
21 Jul 2022 |
9,324 |
9,324
|
-
|
|
-
|
Restricted Stock Units |
|
Eran Broshy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jul 2022 |
9,360 |
9,360
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.46 per share. |
01 Jul 2022 |
884 |
275,215
|
-
|
21.5 |
18,971
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
08 Jun 2022 |
10,000 |
88,490
|
-
|
19.2 |
191,600
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 19.59 per share. |
02 Jun 2022 |
100,000 |
1,142,797
|
-
|
19.6 |
1,959,000
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 19.52 per share. |
02 Jun 2022 |
50,000 |
1,092,797
|
-
|
19.5 |
976,000
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 19.55 per share. |
02 Jun 2022 |
100,000 |
1,242,797
|
-
|
19.6 |
1,955,000
|
Common Stock |
|
Cynthia Collins
|
Director |
|
17 May 2022 |
9,067 |
9,067
|
-
|
|
-
|
Restricted Stock Units |
|
Mason P. Slaine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
9,067 |
9,067
|
-
|
|
-
|
Restricted Stock Units |
|
Matthew M. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
9,067 |
9,067
|
-
|
|
-
|
Restricted Stock Units |
|
James E. Cashman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
9,067 |
9,067
|
-
|
|
-
|
Restricted Stock Units |
|
Nancy Killefer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
9,067 |
9,067
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2022 |
109,740 |
109,740
|
-
|
|
-
|
Restricted Stock Units |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
01 Apr 2022 |
9,255 |
2,168,796
|
-
|
21.5 |
198,797
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. |
01 Apr 2022 |
1,982 |
226,723
|
-
|
21.5 |
42,573
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2022 |
25,939 |
25,939
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2022 |
25,939 |
25,939
|
-
|
|
-
|
Restricted Stock Units |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. |
01 Apr 2022 |
2,870 |
276,099
|
-
|
21.5 |
61,648
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. |
01 Apr 2022 |
2,326 |
394,764
|
-
|
21.5 |
49,962
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2022 |
25,939 |
25,939
|
-
|
|
-
|
Restricted Stock Units |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2022 |
19,953 |
19,953
|
-
|
|
-
|
Restricted Stock Units |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Apr 2022 |
1,723 |
209,564
|
-
|
21.5 |
37,010
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. |
01 Apr 2022 |
1,914 |
248,577
|
-
|
21.5 |
41,113
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2022 |
15,962 |
15,962
|
-
|
|
-
|
Restricted Stock Units |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2022 |
39,906 |
39,906
|
-
|
|
-
|
Restricted Stock Units |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. |
01 Apr 2022 |
3,973 |
492,870
|
-
|
21.5 |
85,340
|
Common Stock |
|
Nicolette D. Sherman
|
CHIEF HUMAN RESOURCES OFFICER |
|
01 Apr 2022 |
11,972 |
11,972
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
01 Apr 2022 |
3,352 |
98,490
|
-
|
22.3 |
74,716
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
01 Apr 2022 |
25,939 |
25,939
|
-
|
|
-
|
Restricted Stock Units |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
01 Apr 2022 |
1,532 |
101,842
|
-
|
21.5 |
32,907
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 20.25 per share. |
16 Mar 2022 |
125,000 |
1,342,797
|
-
|
20.3 |
2,531,250
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 20.17 per share. |
16 Mar 2022 |
125,000 |
1,467,797
|
-
|
20.2 |
2,521,250
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
16 Mar 2022 |
62,485 |
2,178,051
|
-
|
20.2 |
1,260,322
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
16 Mar 2022 |
3,000 |
211,287
|
-
|
20 |
60,000
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
11 Mar 2022 |
27,515 |
2,240,536
|
-
|
20.3 |
558,279
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
18 Feb 2022 |
4,706 |
2,268,051
|
-
|
23.9 |
112,615
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
18 Feb 2022 |
70,294 |
2,272,757
|
-
|
23.3 |
1,638,553
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
17 Feb 2022 |
30,075 |
2,349,569
|
-
|
24.9 |
749,770
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
17 Feb 2022 |
6,518 |
2,343,051
|
-
|
25.5 |
166,144
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
17 Feb 2022 |
53,407 |
2,379,644
|
-
|
23.8 |
1,272,689
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 26.80 per share. |
01 Feb 2022 |
14,801 |
1,592,797
|
-
|
26.8 |
396,667
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 26.53 per share. |
01 Feb 2022 |
35,199 |
1,607,598
|
-
|
26.5 |
933,829
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
26 Jan 2022 |
23,804 |
2,484,247
|
-
|
24.7 |
588,435
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
26 Jan 2022 |
51,196 |
2,433,051
|
-
|
25.7 |
1,314,201
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
26 Jan 2022 |
3,000 |
214,287
|
-
|
26.0 |
78,030
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 27.50 per share. |
20 Jan 2022 |
5,000 |
397,090
|
-
|
27.5 |
137,500
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 28.57 per share. |
03 Jan 2022 |
40,323 |
1,652,474
|
-
|
28.6 |
1,152,028
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 28.88 per share. |
03 Jan 2022 |
9,677 |
1,642,797
|
-
|
28.9 |
279,472
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
27 Dec 2021 |
3,000 |
222,287
|
-
|
29.3 |
87,900
|
Common Stock |
|
James E. Cashman
|
Director |
Sale of securities on an exchange or to another person at price $ 29.20 per share. |
23 Dec 2021 |
25,111 |
438,782
|
-
|
29.2 |
733,241
|
Common Stock |
|
James E. Cashman
|
Director |
Sale of securities on an exchange or to another person at price $ 29.00 per share. |
22 Dec 2021 |
19,889 |
463,893
|
-
|
29 |
576,781
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
22 Dec 2021 |
75,000 |
2,508,051
|
-
|
28.6 |
2,143,500
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 28.00 per share. |
20 Dec 2021 |
7,500 |
250,491
|
-
|
28 |
210,000
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 26.13 per share. |
17 Dec 2021 |
5,000 |
257,991
|
-
|
26.1 |
130,650
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 28.55 per share. |
13 Dec 2021 |
100 |
1,692,797
|
-
|
28.6 |
2,855
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 28.05 per share. |
13 Dec 2021 |
49,900 |
1,692,897
|
-
|
28.1 |
1,399,695
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
07 Dec 2021 |
54,849 |
2,583,051
|
-
|
27.8 |
1,525,899
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
07 Dec 2021 |
15,151 |
2,637,900
|
-
|
27.6 |
417,865
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
03 Dec 2021 |
3,500 |
2,653,051
|
-
|
26.5 |
92,890
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
03 Dec 2021 |
66,500 |
2,656,551
|
-
|
26.0 |
1,728,335
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
24 Nov 2021 |
127,521 |
2,740,530
|
-
|
28.4 |
3,621,596
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
24 Nov 2021 |
17,479 |
2,723,051
|
-
|
28.7 |
500,948
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 29.74 per share. |
22 Nov 2021 |
376,149 |
1,742,797
|
-
|
29.7 |
11,187,047
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
19 Nov 2021 |
70,000 |
2,868,051
|
-
|
30.3 |
2,121,700
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 30.30 per share. |
19 Nov 2021 |
20,000 |
262,991
|
-
|
30.3 |
606,000
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
15 Nov 2021 |
14,700 |
230,587
|
-
|
37.9 |
556,395
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
15 Nov 2021 |
700 |
248,287
|
-
|
38.6 |
26,992
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
15 Nov 2021 |
49,300 |
248,987
|
-
|
37.8 |
1,865,512
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
15 Nov 2021 |
5,000 |
225,287
|
-
|
39.0 |
194,800
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
15 Nov 2021 |
300 |
230,287
|
-
|
38.7 |
11,598
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
15 Nov 2021 |
3,000 |
245,287
|
-
|
39.0 |
116,880
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 37.83 per share. |
15 Nov 2021 |
65,896 |
497,613
|
-
|
37.8 |
2,492,846
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 38.57 per share. |
15 Nov 2021 |
770 |
496,843
|
-
|
38.6 |
29,699
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Sale of securities on an exchange or to another person at price $ 40.06 per share. |
11 Nov 2021 |
4,592 |
278,969
|
-
|
40.1 |
183,956
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Sale of securities on an exchange or to another person at price $ 39.43 per share. |
11 Nov 2021 |
16,962 |
283,561
|
-
|
39.4 |
668,812
|
Common Stock |
|
Patrick F Smith
|
PRESIDENT, INTEGRATED DRUG DEV |
|
01 Nov 2021 |
3,631 |
103,374
|
-
|
|
0
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
27 Oct 2021 |
74,800 |
2,938,251
|
-
|
39.2 |
2,935,152
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
27 Oct 2021 |
200 |
2,938,051
|
-
|
39.8 |
7,952
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 39.95 per share. |
26 Oct 2021 |
3,000 |
402,090
|
-
|
40.0 |
119,850
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
26 Oct 2021 |
3,000 |
298,287
|
-
|
40.0 |
119,850
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 38.60 per share. |
21 Oct 2021 |
6,116 |
405,090
|
-
|
38.6 |
236,078
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 38.58 per share. |
20 Oct 2021 |
12,674 |
411,206
|
-
|
38.6 |
488,963
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 38.55 per share. |
19 Oct 2021 |
1,210 |
423,880
|
-
|
38.6 |
46,646
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 38.56 per share. |
19 Oct 2021 |
483 |
282,991
|
-
|
38.6 |
18,624
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 38.15 per share. |
19 Oct 2021 |
18,083 |
283,474
|
-
|
38.1 |
689,866
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 37.05 per share. |
19 Oct 2021 |
1,434 |
301,557
|
-
|
37.1 |
53,130
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 37.33 per share. |
18 Oct 2021 |
4,618 |
563,509
|
-
|
37.3 |
172,390
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 36.42 per share. |
18 Oct 2021 |
62,049 |
568,127
|
-
|
36.4 |
2,259,825
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 37.38 per share. |
15 Oct 2021 |
5,000 |
425,090
|
-
|
37.4 |
186,900
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
15 Oct 2021 |
5,000 |
301,287
|
-
|
37.4 |
186,900
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Sale of securities on an exchange or to another person at price $ 34.24 per share. |
01 Oct 2021 |
2,767 |
300,523
|
-
|
34.2 |
94,742
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Sale of securities on an exchange or to another person at price $ 33.39 per share. |
01 Oct 2021 |
16,587 |
303,290
|
-
|
33.4 |
553,840
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 36.00 per share. |
27 Sep 2021 |
3,000 |
430,090
|
-
|
36 |
108,000
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
27 Sep 2021 |
3,000 |
306,287
|
-
|
36 |
108,000
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
22 Sep 2021 |
16,854 |
3,013,051
|
-
|
36.8 |
620,733
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
22 Sep 2021 |
58,146 |
3,029,905
|
-
|
36.2 |
2,107,211
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 35.03 per share. |
20 Sep 2021 |
18,570 |
630,176
|
-
|
35.0 |
650,507
|
Common Stock |
|
Michael Andrew Schemick
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 34.46 per share. |
20 Sep 2021 |
48,097 |
648,746
|
-
|
34.5 |
1,657,423
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 35.32 per share. |
17 Sep 2021 |
6,265 |
316,726
|
-
|
35.3 |
221,280
|
Common Stock |
|
Jieun W. Choe
|
CHIEF STRATEGY & MARKETING |
Sale of securities on an exchange or to another person at price $ 35.96 per share. |
17 Sep 2021 |
13,735 |
302,991
|
-
|
36.0 |
493,911
|
Common Stock |
|
Mason P. Slaine
|
Director |
Sale of securities on an exchange or to another person at price $ 29.80 per share. |
13 Sep 2021 |
620,668 |
2,118,946
|
-
|
29.8 |
18,495,286
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Sale of securities on an exchange or to another person at price $ 32.40 per share. |
09 Sep 2021 |
6,241 |
273,687
|
-
|
32.4 |
202,208
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Sale of securities on an exchange or to another person at price $ 36.10 per share. |
09 Sep 2021 |
500 |
228,705
|
-
|
36.1 |
18,050
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Sale of securities on an exchange or to another person at price $ 35.25 per share. |
09 Sep 2021 |
24,085 |
229,205
|
-
|
35.2 |
848,996
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Sale of securities on an exchange or to another person at price $ 34.50 per share. |
09 Sep 2021 |
15,447 |
253,290
|
-
|
34.5 |
532,922
|
Common Stock |
|
Leif E. Pedersen
|
PRESIDENT, SOFTWARE |
Sale of securities on an exchange or to another person at price $ 33.38 per share. |
09 Sep 2021 |
4,950 |
268,737
|
-
|
33.4 |
165,231
|
Common Stock |
|
Craig R. Rayner
|
PRESIDENT, INTEGRATED DRUG DEV |
Sale of securities on an exchange or to another person at price $ 34.15 per share. |
02 Sep 2021 |
1,900 |
364,672
|
-
|
34.2 |
64,885
|
Common Stock |
|
Craig R. Rayner
|
PRESIDENT, INTEGRATED DRUG DEV |
Sale of securities on an exchange or to another person at price $ 37.21 per share. |
02 Sep 2021 |
200 |
316,010
|
-
|
37.2 |
7,442
|
Common Stock |
|
Craig R. Rayner
|
PRESIDENT, INTEGRATED DRUG DEV |
Sale of securities on an exchange or to another person at price $ 36.64 per share. |
02 Sep 2021 |
48,462 |
316,210
|
-
|
36.6 |
1,775,648
|
Common Stock |
|
Craig R. Rayner
|
PRESIDENT, INTEGRATED DRUG DEV |
Sale of securities on an exchange or to another person at price $ 33.51 per share. |
02 Sep 2021 |
3,900 |
366,572
|
-
|
33.5 |
130,689
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Sale of securities on an exchange or to another person at price $ 34.24 per share. |
01 Sep 2021 |
800 |
319,877
|
-
|
34.2 |
27,392
|
Common Stock |
|
Robert Aspbury
|
PRESIDENT, SIMCYP |
Sale of securities on an exchange or to another person at price $ 33.76 per share. |
01 Sep 2021 |
18,554 |
320,677
|
-
|
33.8 |
626,383
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Sep 2021 |
19,409 |
319,878
|
-
|
33.7 |
653,307
|
Common Stock |
|
Richard M. Traynor
|
SVP AND GENERAL COUNSEL |
|
01 Sep 2021 |
10,591 |
309,287
|
-
|
34.1 |
360,729
|
Common Stock |
|
Justin Edge
|
PRES., REGULATORY & ACCESS |
Sale of securities on an exchange or to another person at price $ 33.50 per share. |
30 Aug 2021 |
9,000 |
433,090
|
-
|
33.5 |
301,500
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
25 Aug 2021 |
50,692 |
3,088,051
|
-
|
31.4 |
1,590,208
|
Common Stock |
|
William F. Feehery
|
Director, CHIEF EXECUTIVE OFFICER |
|
25 Aug 2021 |
24,308 |
3,138,743
|
-
|
31.1 |
755,493
|
Common Stock |